Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin safety and pharmacokinetics in chronic liver disease
ACTRN12619001292167Phase 4Completed
- Sponsor
- St Vincent's Hospital
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of metformin in chronic liver disease (CLD) and type 2 diabetes mellitus (T2DM), sponsored by St Vincent's Hospital. Primary endpoint: Safety of metformin in chronic liver disease. Started Jul 2014; status: completed.
02
Drugs
metformin
03
Conditions
chronic liver disease (CLD)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ACTRN12619001292167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619001292167.